Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikael Hoffmann

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Lakartidningen|February 18, 2015
[The physician's different roles and responsibility for the patient's medication list]Mikael Hoffmann, Rikard Lövström
Lakartidningen|April 3, 2012
[Important symbol put requirements]Mikael Hoffmann, Rikard Lövström
Basic & Clinical Pharmacology & Toxicology|November 22, 2022
Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an exampleMikael Hoffmann, Henrik Støvring
Lakartidningen|May 21, 2020
Mikael Hoffmann, Ylva Böttiger
European Journal of Clinical Pharmacology|October 11, 2019
Evidence synthesis based on non-randomised studies-a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockersSusanna M Wallerstedt, Mikael Hoffmann
European Journal of Clinical Pharmacology|October 17, 2024
Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problemSusanna M Wallerstedt, Mikael Hoffmann
British Journal of Clinical Pharmacology|December 9, 2016
Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register dataSusanna M Wallerstedt, Mikael Hoffmann
Lakartidningen|February 28, 2018
Mikael Hoffmann, Rikard Lövström, Håkan Nordgren
Lakartidningen|September 15, 2022
[Pharmacological knowledge bases in Sweden: successes and future in a time of information overflow]Lars Gustafsson, Birgit Eiermann, Mikael Hoffmann
European Journal of Pain (London, England)|February 2, 2022
Comment on Häuser et al.: Medical use of opioids in Europe-Methodological concerns about data from the International Narcotics Control BoardEmmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Lakartidningen|February 18, 2015
[The physician's different roles and responsibility for the patient's medication list]Mikael Hoffmann, Rikard Lövström
Lakartidningen|April 3, 2012
[Important symbol put requirements]Mikael Hoffmann, Rikard Lövström
Basic & Clinical Pharmacology & Toxicology|November 22, 2022
Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an exampleMikael Hoffmann, Henrik Støvring
Lakartidningen|May 21, 2020
Mikael Hoffmann, Ylva Böttiger
European Journal of Clinical Pharmacology|October 11, 2019
Evidence synthesis based on non-randomised studies-a critical review of studies leading to conclusions on fall risk properties of loop diuretics/beta-blockersSusanna M Wallerstedt, Mikael Hoffmann
European Journal of Clinical Pharmacology|October 17, 2024
Quantification of the prevalence of harms in healthcare related to drug treatment: reflections regarding the use of definitions developed for other settings to estimate the magnitude of the problemSusanna M Wallerstedt, Mikael Hoffmann
British Journal of Clinical Pharmacology|December 9, 2016
Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register dataSusanna M Wallerstedt, Mikael Hoffmann
Lakartidningen|February 28, 2018
Mikael Hoffmann, Rikard Lövström, Håkan Nordgren
Lakartidningen|September 15, 2022
[Pharmacological knowledge bases in Sweden: successes and future in a time of information overflow]Lars Gustafsson, Birgit Eiermann, Mikael Hoffmann
European Journal of Pain (London, England)|February 2, 2022
Comment on Häuser et al.: Medical use of opioids in Europe-Methodological concerns about data from the International Narcotics Control BoardEmmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Pageof 7